AVGO vs CGON · P/E 87, rev $41.50B vs rev $4.0M
Broadcom Inc (AVGO) versus CG Oncology, Inc. Common stock (CGON) — a side-by-side from cached financials, not a winner call.
Broadcom Inc (AVGO) is a semiconductors company listed on US. It is led by Hock Tan.
CG Oncology, Inc. Common stock (CGON) is a biotechnology company listed on US.
Latest reported AVGO revenue for 2026-05-03 was $41.50B. Net income was $16.66B. AVGO currently screens at market cap $2.12T and trailing P/E 86.9.
Latest reported CGON revenue for 2025-12-31 was $4.0M. Net income was -$161.0M. Revenue was up 254.7% from 2024-12-31 to 2025-12-31. CGON currently screens at market cap $4.74B.
AVGO currently screens at market cap $2.12T and trailing P/E 86.9. CGON currently screens at market cap $4.74B.
Not investment advice. Open the AVGO and CGON stock pages for the full models.
Not investment advice.